MedTrace Logo

Measuring Erythrocyte Iron Incorporation From Different Dosing Regimens in Anemic Women

NCT03623997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-08-22

No results posted yet for this study

Summary

Iron-deficient anaemic subjects are likely to benefit most from oral iron supplements, but supplementation schedules vary widely in clinical practice, absorption is low and compliance is poor due to mild gastrointestinal side effects. The investigators will compare iron absorption from labeled oral iron doses of 100mg and 200mg administered either on two consecutive days or on alternate days in young anemic women.

Conditions

Interventions

OTHER

Iron stable isotope labeled iron(II) sulfate

Administration of oral stable isotope labels using different dosings and different regimens in women with iron deficiency anemia

Sponsors & Collaborators

  • Swiss Federal Institute of Technology

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-10
Primary Completion
2018-01-08
Completion
2018-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03623997 on ClinicalTrials.gov